Biodexa Pharmaceuticals Cash Flow Statement (2013-2025) | BDRX

Cash Flow Statement Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Jun2019 Dec2019 Sep2020 Dec2020 Sep2021 Dec2021 Sep2022 Dec2022 Jun2023 Dec2023 Dec2024 Jun2025
Operating Activities
Net Income (Quarter) -6.61M-13.98M-15.33M-25.07M-5.79M-6.00M-5.68M-21.94M-23.00M-4.38M-8.55M-4.62M-10.42M-4.83M-9.29M-4.57M-5.30M
Depreciation and Depletion (Quarter) 0.16M0.11M0.12M0.09M
Share-based Compensation (Quarter) -0.09M0.03M-0.60M-0.62M0.05M
Cash from Discontinued Operations (Quarter) 2.24M-6.92M
Gains from Sales and Divestitures (Quarter) 11.91M
Gains from Investment Securities (Quarter) 0.04M
Asset Writedowns and Impairment (Quarter) 14.60M15.31M
Cash from Restructuring (Quarter) -3.84M
Cash from Operations (Quarter) -7.18M-8.64M-18.85M-16.27M-5.86M-8.93M-9.36M-4.32M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.01M
Depreciation & Amortization (CF) (Quarter) 0.16M0.11M0.12M0.09M
Change in Working Capital
Change in Receivables (Quarter) -0.72M-2.34M-0.30M0.08M-0.62M-0.65M-1.19M
Change in Inventory (Quarter) -0.09M-0.29M
Change in Account Payables (Quarter) -0.53M-0.06M0.09M0.09M1.13M
Change in Taxes (Quarter) -1.29M-1.61M-1.72M-11.39M-1.07M-0.55M-0.58M-0.33M
Other Working Capital Changes (Quarter) -0.12M-0.13M
Investing Activities
Capital Expenditures (Quarter) -0.08M-1.63M-1.40M-1.67M-0.03M-0.11M-0.12M-0.26M-0.25M-0.04M-0.04M
Sales of Property, Plant and Equipment (Quarter) 12.03M0.06M0.01M0.01M
Acquisitions (Quarter) 3.87M
Cash from Investing Activities (Quarter) -0.08M-1.44M-2.33M-0.01M-1.25M-0.11M-0.12M-0.20M-0.20M-0.02M-0.02M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Repayments (Quarter) -0.32M-0.55M-0.25M-0.29M
Change in Capital Stock
Net Shares Issued and Repurchased (Quarter) -0.21M-0.01M0.00M-0.01M
Misc.
Cash from Financing Activities (Quarter) -0.33M0.05M-0.01M15.73M0.48M0.51M-0.11M-0.11M-0.10M-0.09M
Exchange Rate Effect (Quarter) -0.06M-0.05M-0.08M0.24M0.25M-0.01M-0.01M
Change in Cash (Quarter) -21.51M8.61M-8.55M-8.97M-4.64M-4.50M-4.49M-4.26M
Beginning Cash Balance (Quarter) 3.01M13.76M14.43M10.49M10.17M12.44M11.80M
Free Cash Flow (Quarter) -7.11M-7.01M-17.45M-14.59M-5.84M-8.81M-9.24M-4.06M0.25M0.04M0.04M
Net Cash Flow (Quarter) -7.26M-10.08M-21.51M-16.28M0.05M-0.01M8.61M-8.55M-8.97M-4.64M-0.31M-0.12M-0.11M